At a glance
ClinicalIndex Comparison RecordN/ACompleted· 57 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effect Of Methylphenıdate Treatment On Neuroınflammatıon Levels In Chıldren Wıth Attentıon Defıcıt Hyperactıvıty Dısorder
In Brief
An observational study for Attention Deficit Disorder With Hyperactivity (ADHD). Completed, enrolled 57 participants across 1 site.
Detailed Summary
The aim of this study was to investigate the effect of treatment of ADHD with methylphenidate on neuroinflammation by examining the levels of Interleukin-6 (IL-6), S100B, Claudin-5 in serum samples of patients who were diagnosed with attention deficit hyperactivity disorder (ADHD) and started or planned to start methylphenidate for treatment as per routine, at month 0 before the initiation of methylphenidate treatment and at month 3 after the initiation of treatment.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesTurkey (Türkiye)
Collaborators--
Timeline
N/ACompletedFinished
2026
First PostedJun 2025
Enrollment StartJul 2025
Primary CompletionOct 2025
Study CompletionDec 2025
TodayJul 2026
First PostedJun 27, 2025
Enrollment StartJul 14, 2025
Primary CompletionOct 19, 2025
Study CompletionDec 31, 2025
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 1.0 years ago